baber/WOPTO huggingface dataset:
Patent CY-1116267-T1 (CY)
Title: Μεθοδοι για τη θεραπεια της ενδομητριωσης
Inventor: BOVINDARAJAN MIRUDHUBASHINI
IPC: A61K31/57
Filed: 2015-04-24
Abstract: Η ενδομητρίωση, η οποία περιλαμβάνει την εξωτερική ενδομητρίωση, το ενδομητρίωμα, την αδενομύωση, τα αδενομυώματα, τα αδενομυωτικά οζίδια των ιερομητρικών συνδέσμων, καθώς και τα ενδομητριωτικά οζίδια, όπως η ενδομητρίωση από ουλές, υποβάλλεται αποτελεσματικά σε θεραπεία με τη χορήγηση ενός προγεσταγόνου εντός της αλλοίωσης, συμπεριλαμβανομένης της διακολπικής, ενδοσκοπικής ή ανοικτής χειρουργικής χορήγησης που περιλαμβάνει τη λαπαροτομία. Παρέχονται επίσης συνθέσεις για αυτήν.
Patent CY-1117280-T1 (CY)
Title: Χρηση ωμεγα λιπαρων οξεων για την θεραπεια ασθενειας
Inventor: GEORGIOU TASSOS
IPC: A61P27/02
Filed: 2015-11-18
Abstract: Εικοσαπεντανοϊκό οξύ (ΕΡΑ) και δοκοσαεξανοϊκό οξύ (DHA), ή άλας ή εστέρας εκ τούτου, παρέχονται για την χρήση στη θεραπεία και/ή προφύλαξη ασθένειας επιλεγμένη από οίδημα ωχράς κηλίδας, ασθένειες που προκαλούν βλάβη στους φωτοϋποδοχείς του αμφιβληστροειδούς και/ή επιθηλιακών κυττάρων χρωστικής ουσίας του αμφιβληστροειδούς, και ξηροφθαλμία σε θηλαστικό, όπου η συνδυασμένη δόση εικοσαπεντανοϊκού οξύ και δοκοσαεξανοϊκού οξύ είναι μεταξύ 5 mmol και 25 mmol την ημέρα, και όπου η μοριακή αναλογία του εικοσαπεντανοϊκού οξύ και δοκοσαεξανοϊκού οξύ διακυμαίνεται μεταξύ 1:1 και 5:1. Οι συνδέσεις που περιλαμβάνουν ΕΡΑ και DHA και τουλάχιστον έναν φαρμακευτικά αποδεχτό έκδοχο που συμπεριλαμβάνει ΕΡΑ, DHA και περαιτέρω θεραπευτικοί παράγοντες παρέχονται επίσης. Το ΕΡΑ και DHA, ή η σύνδεση που περιλαμβάνει το ΕΡΑ και DHA μπορεί να χορηγείται από το στόμα.
Patent CY-1117552-T1 (CY)
Title: Μεθοδος για σταθεροποihση υδροξειδιου χαλκου
Inventor: OBERHOLZER MATTHEW RICHARD
IPC: C01G3/02
Filed: 2016-05-24
Abstract: Αποκαλύπτεται μέθοδος σταθεροποίησης υδροξειδίου χαλκού(ΙΙ), η οποία μέθοδος περιλαμβάνει τα διαδοχικά στάδια: (α) συνδυασμό υδροξειδίου χαλκού(ΙΙ), υδατοδιαλυτού φωσφορικού και ύδατος για να σχηματιστεί μείγμα· και (β) ξήρανση του μείγματος. Επίσης αποκαλύπτεται σταθεροποιημένο υδροξείδιο χαλκού(ΙΙ) παρασκευασμένο σύμφωνα με την εν λόγω μέθοδο και σύνθεση περιλαμβάνουσα σταθεροποιημένο υδροξείδιο χαλκού(ΙΙ) παρασκευασμένο σύμφωνα με την εν λόγω μέθοδο και τουλάχιστον ένα από επιφανειοδραστικό. στερεό αραιωτή ή υγρό αραιωτή.
Patent CY-1118395-T1 (CY)
Title: Μια διαδικασια για την παρασκεyh αλειφατικων και κυκλικων υδρογονανθρακων
Inventor: VASICEK ALOIS
IPC: C10G3/00
Filed: 2016-06-30
Abstract: Μία φυσική ουσία ή ένα μείγμα φυσικών ουσιών, κυρίως με βάση τα λιπαρά οξέα, τις αλκοόλες, τους σακχαρίτες και τα λιπίδια, κατά προτίμηση τα λίπη και τους κηρούς, αναμειγνύεται με έναν παράγοντα αποξείδωσης ο οποίος ενεργοποιείται από την επίδραση της ακτινοβολίας ενός τοπικού πεδίου βαθμίδων υπερύθρων και ηλεκτρομαγνητικών ακτινοβολιών που συν-ενεργούν. Λόγω της σύνθεσης του παράγοντα αποξείδωσης, εξαλείφεται το οξυγόνο από τη χημική δομή των φυσικών ουσιών και σχηματίζονται αλειφατικοί και κυκλικοί υδρογονάνθρακες που έχουν C1 έως C25 άτομα στο μόριο.
Patent CY-1118231-T1 (CY)
Title: Συνθεση λιποσωματος
Inventor: KIKUCHI HIROSHI
IPC: A61K47/02
Filed: 2016-09-14
Abstract: Η παρούσα εφεύρεση παρέχει μια νέα σύνθεση λιποσώματος που περιέχει εριβουλίνη ή το φαρμακολογικά επιτρεπόμενο άλας της, και την μέθοδο παρασκευής της.
Patent CY-1118240-T1 (CY)
Title: ΠΑΡΑΛΛΑΓΕΣ CRIg ΩΡΙΜΑΣΜΕΝΗΣ ΣΥΓΓΕΝΕΙΑΣ
Inventor: SIDHU SACHDEV S
IPC: C07K14/705
Filed: 2016-11-17
Abstract: Η παρούσα εφεύρεση αφορά παραλλαγές CRIg ωριμασμένης συγγένειας. Συγκεκριμένα, η εφεύρεση αφορά παραλλαγές CRIg που έχουν αυξημένη συγγένεια δέσμευσης με C3b και διατηρούν επιλεκτική δέσμευση σε C3b συγκριτικά με C3.
Patent CY-1118421-T1 (CY)
Title: Μια μεθοδος αποδιαμορφωσης με τη χρηση λογικης αποφασης για διαμορφωση ευρους τετραγωνισμου και η συσκευη αυτης
Inventor: SEO HONG-SEOK
IPC: H04L27/26
Filed: 2017-01-12
Abstract: Η παρούσα εφεύρεση αφορά σε μια μέθοδο αποδιαμόρφωσης με τη χρήση λογικής απόφασης για QAM (Διαμόρφωση Εύρους Τετραγωνισμού). Σε μια μέθοδο λογικής απόφασης για αποδιαμόρφωση ενός ληφθέντος σήματος του τετράγωνου QAM που αποτελείται από την ίδια συνιστώσα σήματος φάσης και μια συνιστώσα ορθογώνιου σήματος φάσης, με τη μέθοδο αποδιαμόρφωσης να χρησιμοποιεί την λογική απόφαση να έχει ένα χαρακτηριστικό όπου η ταχύτητα επεξεργασίας βελτιώνεται, και το κόστος κατασκευής μειώνεται από το κέρδος μιας τιμής υπό όρους διανύσματος πιθανοτήτων, που είναι κάθε τιμή λογικής απόφασης, που αντιστοιχεί σε μια θέση bit της υλικής απόφασης, χρησιμοποιώντας μια συνάρτηση που περιλαμβάνει μια λειτουργία κρίσης συνθήκης από μια τιμή συνιστώσας ορθογώνιας φάσης ενός ληφθέντος σήματος και την ίδια τιμή συνιστώσας φάσης.
Patent CY-1124082-T1 (CY)
Title: Μεθοδοι θεραπειας με χρηση κινητοποιητων βλαστικων κυτταρων και ανοσοκατασταλτικων παραγοντων
Inventor: SUN ZHAOLI
IPC: A61K38/13
Filed: 2021-02-22
Abstract: Η παρούσα εφεύρεση σχετίζεται με το πεδίο της μεταμόσχευσης οργάνων. Σε μια πτυχή, η παρούσα εφεύρεση παρέχει μεθόδους θεραπείας ενός λήπτη μοσχεύματος οργάνου που περιλαμβάνει χορήγηση στο λήπτη μιας θεραπευτικά αποτελεσματικής ποσότητας ενός κινητοποιητή βλαστικών κυττάρων και ενός ανοσοκατασταλτικού παράγοντα. Σε συγκεκριμένους τρόπους υλοποίησης, η παρούσα εφεύρεση παρέχει μια μέθοδο θεραπείας ενός λήπτη μοσχεύματος οργάνου που περιλαμβάνει χορήγηση στο λήπτη μιας θεραπευτικά αποτελεσματικής ποσότητας ενός παράγοντα που κινητοποιεί τα βλαστικά κύτταρα CD34+ και/ή CD133+ και ενός χαμηλής δόσης ανοσοκατασταλτικού παράγοντα.
Patent GR-910300062-T1 (GR)
Title: A process for the optical resolution of dropropizine
Inventor: GIANI ROBERTO
IPC: C07B57/00
Filed: 1991-11-15
Abstract: A process for the optical resolution of racemic dropropizine, carried out using L(+)tartaric acid as the optical resolution agent in aqueous medium, is described.
Patent GR-940300019-T1 (GR)
Title: New water-soluble, biologically decomposable carbonic acid polyesters and their use as preparing and slip additives of synthetic fibres.
Inventor: GOOSSENS BERNHARD
IPC: D01F1/10
Filed: 1994-04-29
Abstract: Water-soluble, biodegradable carbonic acid polyesters of the formula   <IMAGE>  in which:   R1 is a linear or branched, saturated or monounsaturated alkyl radical having 6 to 22 carbon atoms,   R2 is hydrogen or a methyl group,   R3 is hydrogen or <IMAGE> ,   n is an integer from 0 to 10,   m is an integer from 5 to 16,   z is an integer from 1 to 3, and the use thereof as finishing agents and lubricants for synthetic fibres.
Patent SI-1050531-T1 (SI)
Title: Pyridine and piperidine derivatives for treating neurodegenerative diseases
Inventor: METH-COHN OTTO
IPC: A61K31/4402
Filed: 2000-05-02
Abstract: Pyridine and piperidine derivatives (I) are new. Pyridine and piperidine derivatives of formula (I), their enantiomers and diastereoisomers, acid and base salts, are new. A = pyridine, pyridinium, or piperidine; R2 = H; R3 = OH, or together with R2 forms oxo; R4 = phenyl, naphthyl or heteroaryl (all optionally substituted); R1 = H or R1 - R4, together with the two C atoms to which they are attached, form a 6C ring, or R1 and R2 form a bond, in which case R3 is a 5- or 6-membered heterocycle linked through N and which may contain a further hetero atom (O, N, S); R5 = a 5-6 membered heterocycle linked through N optionally containing a hetero atom (O, N, S), or a group of formula (II); R'1-R'4 = have the same meanings as R1-R4, or they may be H, in which case R4 is not unsubstituted phenyl, naphthyl, or heteroaryl; R6 = H, 1-6C alkyl or absent; with the provisos that (a) when A = piperidine, R2-R3 form oxo, R5 = H, and R6 =H or is absent, then R4 is other than phenyl substituted by one group OH, alkoxy, CF3, or halogen other than Br, or by more than one group OH and alkoxy, (b) when R2 = H, R3 = OH, R5 = H, R6 = H or is not there, then R4 is not phenyl substituted by one Cl, OH, alkoxy or alkyl group, or by more than one OH or alkoxy group and (c) (I) is not 1-(1,3-benzodioxol-5-yl)-2-(2-pyridinyl) ethanol or 2-(2-pyridinyl) cyclohexanone.
Patent SI-1252268-T1 (SI)
Title: Method of reducing the vapour pressure of ethanol-containing motor fuels for spark ignition combustion engines
Inventor: HULL ANGELICA
IPC: C10L1/02
Filed: 2001-01-24
Abstract: Method of reducing the vapour pressure of a C3 to C12 hydrocarbon-based motor fuel mixture containing 0.1 to 20 % by volume of ethanol for conventional spark ignition internal combustion engines, wherein, in addition to an ethanol component (b) and a C3 to C12 hydrocarbon component (a), an oxygen-containing additive (c) selected from at least one of the following types of compounds: alcohol other than ethanol, ketone, ether, ester, hydroxy ketone, ketone ester, and a heterocyclic containing oxygen, is used in the fuel mixture in an amount of at least 0.05 by volume of the total fuel, is disclosed. A mixture of fuel grade ethanol (b) and oxygen-containing additive (c) usable in the method of the invention is also disclosed. <IMAGE>
Patent SI-1511770-T1 (SI)
Title: Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
Inventor: MASSBERG STEFFEN
IPC: C07K16/28
Filed: 2003-06-05
Abstract: The present invention provides a fusion protein comprising (a) the extracellular domain of glycoprotein VI or a variant thereof that is functional for binding to collagen and (b) the Fc domain of an immunoglobulin or a function-conservative part thereof, characterised by a polypeptide chain having an amino acid sequence as shown in Figure 7 and whereby the fusion protein is obtainable by a process which provides the fusion protein in the form of a specific dimer.
Patent SI-1481966-T1 (SI)
Title: Novel arylamidine derivative or salt thereof
Inventor: HAYASHI KAZUYA
IPC: A61K31/44
Filed: 2003-03-04
Abstract: Arylamide derivatives (I) are new. Arylamide derivatives of formula (I) and their salts are new. [Image] X : optionally substituted lower alkylene or alkenylene; G 1O, S or NH; G 2C or N; R aH, halo or optionally substituted alkyl, cycloalkyl or alkoxy; R 1optionally protected or substituted amidino; R 2NR 3R 4, NR 5YNR 6R 7 or a group of formula (i); R 3H, amino protecting group, a group of formula (ii) or optionally substituted cycloalkyl or alkenyl; W : a bond or optionally substituted alkylene; Y coptionally substituted 2-4C alkylene; Y c1optionally substituted 1-4C alkylene; R 7bH, amino protecting group, a group of formula (iii) or optionally substituted alkyl, cycloalkyl or alkenyl; Z : optionally substituted lower alkylene or alkenylene; G 3O, S, NH or bond; G 5C or N; R bH, halo or optionally substituted alkyl, cycloalkyl or alkoxy; R 8para or meta to G 3 and is optionally protected or substituted amidino; R 4-R 6H, amino protecting group or optionally substituted alkyl, cycloalkyl or alkenyl; Y : optionally substituted 2-6C alkyelene or 3-6C alkenylene; R 7R 4 or (iii); Y aoptionally substituted 2-4C alkylene; Y boptionally substituted 1-4C alkylene; G 4C or N; R 7aalkyl (optionally substituted by at least one CN, NO 2, halo, sulfo, phosphoryl, lower alkenyl, lower alkoxy, heterocyclyl, cycloalkyl, lower alkylidene, SH, amidinophenylaryloxy, aryloxy, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, lower alkylcarbamoyl, lower alkylsulfonylamino, lower alkylaminosulfonyl, lower carboxylalkenyl, lower alkoxyimino or optionally protected hydroxyl, amino, carbamoyl, hydrocarbamoyl, aminosulfonyl, cyclic amino or lower alkylamino), (iii) or optionally substituted phenyl, cycloalkyl or alkenyl, provided that when G 1 = NH, then X = optionally substituted 3-6C alkylene or alkenylene. [Image] ACTIVITY : Fungicide. In cytotoxicity assays, 4-[2-[1-(3-[4-[amino(imino)methyl]phenoxy]propyl)-4-piperidinyl]ethoxy]benzamidine hydrochloride (Ia) had an IC 50 value for Candida albicans TIMM1623 of 0.0039 mu g/ml. MECHANISM OF ACTION : None given.
Patent SI-1673391-T1 (SI)
Title: MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
Inventor: HAUSER HANS-PETER
IPC: C12N15/00
Filed: 2004-10-13
Abstract: The present invention relates to modified DNA sequences coding for biologically active recombinant human factor VIII and its derivatives, recombinant expression vectors containing such DNA sequences, host cells transformed with such recombinant expression vectors, and processes for the manufacture of the recombinant human factor VIII and its derivatives. The invention also covers a transfer vector for use in human gene therapy which comprises such modified DNA sequences. The present invention relates to modified DNA sequences coding for biologically active recombinant human factor VIII and its derivatives, recombinant expression vectors containing such DNA sequences, host cells transformed with such recombinant expression vectors, and processes for the manufacture of the recombinant human factor VIII and its derivatives. The invention also covers a transfer vector for use in human gene therapy which comprises such modified DNA sequences.
Patent SI-1611757-T1 (SI)
Title: Method for analysing the interference and supply situation in umts sub-networks
Inventor: BEYER JURGEN
IPC: H04W24/00
Filed: 2004-04-02
Abstract: The invention relates to a method for analyzing the interference and supply situation in universal mobile telecommunication system (UMTS) sub-networks. Said method enables supply assertions for each service in the considered sub-network to be determined using measured data that is recorded either during or without the traffic load of the network.
Patent SI-1794163-T1 (SI)
Title: Method of preparing poly(adp-ribose) polymerases inhibitors
Inventor: MA CHUNRONG
IPC: C07D487/00
Filed: 2005-09-12
Abstract: This invention relates to a new and convergent route to small molecule inhibitors of poly(ADP-ribose) polymerase, such as 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, via a key Sonogashira coupling reaction and a CuI-promoted indole formation.
Patent SI-1846430-T1 (SI)
Title: New macrolides
Inventor: KELLENBERGER JOHANNES LAURENZ
IPC: A61K31/00
Filed: 2006-02-08
Abstract: The present invention relates to new antibiotic macrolide compounds of the general formula I: with improved activity, to medicaments comprising such antibiotics, and to the use of such antibiotics for the treatment of infectious diseases, inflammatory diseases and human diseases or disorders which can be ameliorated by inhibition human phospdiesterases.
Patent SI-2098248-T1 (SI)
Title: Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases
Inventor: MAUS JOACHIM DR
IPC: A61K9/00
Filed: 2006-12-01
Abstract: The invention relates to novel combinations based on anticholinergics, ² 2 -adrenoceptor agonists, and glucocorticoids, process for production and its use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.
Patent SI-2703486-T1 (SI)
Title: Anti-b7-h3 antibody
Inventor: TAKAHASHI SHU
IPC: C07K16/00
Filed: 2012-04-24
Abstract: An antibody exhibiting antitumor activity that binds to B7-H3, a functional fragment of the antibody, a pharmaceutical composition that includes the antibody or the functional fragment, methods for making the antibody or the functional fragment, methods for treating a tumor using the antibody or the functional fragment, and polynucleotides encoding the antibody or the functional fragment.
Patent SI-2999707-T1 (SI)
Title: Tylosin derivatives and method for preparation thereof
Inventor: KLEEFELD GERD
IPC: C07H17/00
Filed: 2014-05-23
Abstract: The present invention relates to new macrolide derivatives, in particular new tylosin derivatives of the formula (IIa), a pharmaceutical or veterinary composition comprising the derivatives; a method for preparation thereof; a method for treating and/or preventing bacterial infections in an animal, wherein the method comprises administering the derivatives or the composition; and a use of the derivatives for the manufacture of medicaments for treating and/or preventing bacterial infections in an animal.
Patent DE-3650482-T2 (DE)
Inventor: PRUDHON FRANCOIS
IPC: B01F23/10
Filed: 1986-12-26
Granted: 1996-08-14
Abstract: The device for the implementation of the process comprises: an envelope (1), into which open the gas inlets arranged so as to form repetitive patterns of elementary mixing (3, 4, 6, 8) and a rigid element (5) inside the chamber (2), the gas inlets opening into the annular zone delimited by said rigid element (5). 
<??>The process and the device find application in particular in depollution. 
<IMAGE>
Patent DE-3852107-T2 (DE)
Inventor: KENNEDY THOMAS
IPC: A61P9/00
Filed: 1988-09-28
Granted: 1995-03-30
Abstract: The disclosure relates to compounds of the formula   <IMAGE>   and pharmaceutically acceptable addition salts thereof wherein X represents a single, direct bond or a substituted or unsubstituted alkylene chain containing 1 to 4 carbon atoms, wherein R5 is a lower alkyl group, wherein R6 is either hydrogen or methyl, wherein Am is selected from the class consisting of amino, lower mono and dialkylamino, piperidino, piperazino, N-lower alkyl piperazino, pyrrolidino, and morpholino groups, wherein Y1 and Y2 are identical and are hydrogen, a halogen, methyl or ethyl048505325 and n is an integer in the range of 1-5.
Patent TR-199801346-T2 (TR)
Inventor: PAHNKE OTTO
IPC: A23P20/20
Filed: 1997-01-20
Abstract: Pasty milk-based food products are disclosed with a high energy content per unit of consumption. The food product essentially consits of milk with 15 wt.% fat, 5-20 wt.% sugar and a thickening system with 1.5-2.5 wt.% starch and 0.1-0.5 % gelling agents which give the food product a pasty structure with a viscosity of at least 3 Pa.s at 10  DEG C. The starch/gelling agent ratio equals 15:1 to 5:1 by weight. Cocoa powder, fruit pulp and aromas can be added to this pasty food product with a high solids content. Preferably, these pasty food products are formed as a multilayer arrangement with different colours and flavours.
Patent TR-199802131-T2 (TR)
Inventor: FEISSEL SOPHIE
IPC: H04N1/00
Filed: 1997-04-25
Abstract: Telephone comprising a radio unit (2) which can receive and provide on two sides analog signals and digital data, a corrector unit (3), a data processing unit (100) comprising a rate adaptor (8) and a fax adaptor (9), input means (14), a control unit (7), the data processing unit (100) and additionally a fax data memory (1,1, 16), the control unit (7) being arranged to control at least one of the two emission and reception functions of said fax data.
Patent TR-199802555-T2 (TR)
Inventor: KLICH MICHEL
IPC: A61P31/00
Filed: 1997-06-10
Abstract: Bulusun konusu, asagidaki (I) formülüne sahip bilesiklerdir. Yukaridaki formülde R1= H, OH, alkil, alkenil ya da gerektiginde ornatilan alkinil ya da alkoksi; R2 = H, Hal; R3 = H, alkil, Hal; R4 = (a), Rg ve Rh: H, alkil, aril ayrik halkasi; R5 = H ya da O-alkil; R6 = alkil ya da CH2-O-alkil ; R7 = H ya da alkil'dir. Formül (I) bilesikleri antibiyotik özelliklere sahiptir.
Patent TR-199900733-T2 (TR)
Inventor: HENKEL JOHN TIMOTHY
IPC: A61K31/351
Filed: 1997-09-29
Abstract: Mupirosin veya bunun tuz veya esteri, özellikle de nazofarenkse uygulanmak üzere uyarlanmis olan yeni bir sprey veya terkipleri ile nükseden sinüzit ve nükseden otitin tedavisi için kullanilabilir.
Patent TR-199901742-T2 (TR)
Inventor: JAMES TIMOTHY W
IPC: F25B41/04
Filed: 1997-11-04
Abstract: A low-cost and thermodynamically efficient implementation of a two-stage refrigeration system applied to a retail refrigerator. The invention includes a simple and easily manufactured thermally efficient and low-cost evaporation unit. The invention further includes a thermal energy storage module and an energy efficient control protocol to maintain steady temperatures in the fresh and frozen food sections, to permit energy efficient defrosting of the heat exchange surfaces in the freezer section, and minimize losses associated with condensing unit on-and-off cycling.
Patent DE-60011075-T2 (DE)
Inventor: ZUDDAS SALVATORE
IPC: F23J3/02
Filed: 2000-03-30
Granted: 2005-06-16
Abstract: Device for cleaning both domestic and industrial chimney flues, also acting as a chimney-pot. The cleaning of the flues is effected by the straight up and down movement of a metal brush (Fig.1) fitted with steel wire bristles (CLEANING PORCUPINE), activated manually by a metal chain (Fig.5) and pulley system (Fig.4) or by a cog-wheel in the case of large industrial chimneys, positioned and fitted into the intrados of a steel plate (Fig.2) which acts as a cover for the device.
Patent DE-60012041-T2 (DE)
Inventor: KLOTS BORIS
IPC: H04L29/08
Filed: 2000-04-18
Granted: 2005-07-07
Abstract: A communication architecture for performing work in a distributed computing environment involves client processes on client nodes sending work requests to a director. The director examines the work requests to determine one or more resources required to perform the work as well as one or more server nodes that can provide the required resources. The director then forwards the work requests to server processes on the server nodes that can provide the required resources. The work requests provided to the server processes specify that the work results are to be provided directly from the server processes to the client processes that made the work requests. The director maintains a table of resource data that specifies the services and/or resources that are provided by and/or made available on the server nodes in the distributed computing environment.
Patent DE-60013229-T2 (DE)
Inventor: NISKANEN REIJO
IPC: B63B29/02
Filed: 2000-11-20
Granted: 2004-12-30
Abstract: A construction arrangement for ships balconies, especially for passenger ships and in particular for ships having a plurality of tiered balconies. The ship is provided with supporting brackets (5) or equivalent constructions which are adapted to receive the load-bearing members (6) comprising floor elements. In preferred embodiments, hollow support pillars (8,8a) are provided, which communicate with channels (12) in the floor elements (6) to provide a sewerage arrangement for disposal of rain water. <IMAGE>
Patent DE-60023697-T2 (DE)
Inventor: JOU YU-CHEUN
IPC: H04B17/00
Filed: 2000-06-22
Granted: 2006-08-10
Abstract: Apparatus and method for use in a mobile station in a wireless communication system, comprising in which: 
a decoder (218) detects if frames received from a base station are good or bad; 
a first counter (224) counts received bad frames; 
a second counter (226) counts received good frames; 
a control processor for resets the first counter (224) to zero and incrementing the second counter (226) by one if a received frame is declared a good frame, and incremens the first counter (224) by one and resetting the second counter (226) to zero if a received frame is declared a bad frame, and disables a transmitter if the value of the first counter (224) reaches a predetermined threshold.
Patent DE-60025522-T2 (DE)
Inventor: FREY JOACHIM
IPC: A61K48/00
Filed: 2000-11-24
Granted: 2006-07-06
Abstract: The invention relates to protein LppQ of <i>Mycoplasma mycoides</i> subsp. <i>mycoides</i> SC, DNA encoding said protein, processes for the preparation of the protein and the DNA, a vector comprising the DNA, a host cell comprising the vector, use of the protein in immunological methods for the detection of <i>M. mycoides</i> subsp. <i>Mycoides</i> SC, use of the DNA in genetic methods for the detection of <i>M. mycoides</i> subsp. <i>mycoides</i> SC, use of the protein and DNA for preparing a vaccine against <i>M. mycoides</i> subsp. <i>mycoides</i>, processes for the immunological detection of antibodies directed to <i>M. mycoids</i> subsp. <i>Mycoides</i> SC and PCR process for the detection of <i>M. mycoides</i> subsp. <i>mycoides</i> SC, a monoclonal antibody specific for LppQ or parts thereof and a diagnostic kit for the detection of an infection with <i>Mycoplasma mycoides</i> subsp. <i>mycoides</i> SC.